Bayer stock: Bayer reports November 3, 2026. Bayer stock falls 1.40 percent

Published on 10/23/2026 at 16:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

First-half sales rose 3.00 percent to EUR 24.30 billion. Bayer stock costs EUR 43.59 on October 23, 2026, 1.40 percent below the Xetra close.

Reporting date and finances

Bayer is scheduled to publish third-quarter results on November 3, 2026.
First-half sales rose 3.00 percent to EUR 24.30 billion.
Bayer stock costs EUR 43.59 at Lang & Schwarz on October 23, 2026 at 4:07 p.m. CEST, 1.40 percent below the Xetra close.
Bayer's market capitalization was EUR 42.9 billion as of October 23, 2026.

Flatlay auf weißem Untergrund: weiße runde Tabletten, Marmorstößel, grünes Pflanzenblatt, Glasflakon und gedrucktes DNA-Doppelhelix-Diagramm; Beschriftungskarte mit Text PHARMA — Top-down-Arrangement: weiße Tabletten, Mörser, grünes Blatt, DNA-Diagramm, Beschriftungskarte PHARMA, Illustration mit AI erstellt.

Bayer (ISIN DE000BAY0017) is scheduled to publish its third-quarter results on November 3, 2026, at 7:30 a.m. CET, according to Bayer. The earnings call is scheduled for 2:00 p.m. CET on the same date. Bayer stock was trading at EUR 43.59 at Lang & Schwarz on October 23, 2026 at 4:07 p.m. CEST, 1.40 percent below the Xetra close of October 22, 2026 at EUR 44.21.

First-half sales set the baseline

Bayer reported first-half sales of EUR 24.30 billion, up 3.00 percent from the prior-year period. Core earnings per share reached EUR 3.66, also 3.00 percent higher than a year earlier, according to the first-half earnings call transcript published by Yahoo Finance. In the second quarter, sales rose 2.00 percent to EUR 10.90 billion, while EBITDA before special items increased 7.00 percent to EUR 6.60 billion in the first half.

Stock stays inside its yearly range

The Xetra-linked quote was EUR 43.70 at 4:04 p.m. CEST on October 23, 2026, with 437,875 shares traded. The 52-week range was EUR 25.78 to EUR 53.92, placing the Lang & Schwarz price 19.15 percent below the high and 69.09 percent above the low. Bayer's market capitalization was EUR 42.9 billion as of October 23, 2026.

Analyst targets and the next date

UBS kept its Buy rating and EUR 62.00 target in a study dated October 14, 2026, reported by T-Online. The target lies 42.28 percent above the Lang & Schwarz price. JPMorgan separately maintained an Overweight rating and EUR 61.00 target in a study dated October 16, 2026, according to T-Online. The next scheduled company date is November 3, 2026, when Bayer publishes third-quarter results and holds its earnings call.

What the November date will test

The results will show whether first-half growth carried into the third quarter. The comparison starts with EUR 24.30 billion of first-half sales and EUR 6.60 billion of first-half EBITDA before special items, while the stock remains 19.15 percent below its 52-week high.

Price and reporting date

Bayer stock was trading at EUR 43.59 at Lang & Schwarz on October 23, 2026 at 4:07 p.m. CEST, 1.40 percent below the Xetra close of October 22, 2026 at EUR 44.21. The next scheduled results date is November 3, 2026. The further course of trading is shown by the continuously updated real-time quote of Bayer stock.